1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Weidler, M. Marx, U.C. Seidel, G. Roesch, P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE FEBS Lett. FEBLAL 0165 0014-5793 444 239 244 10.1016/S0014-5793(98)01658-5 10050767 The structure of human parathyroid hormone-related protein(1-34) in near-physiological solution. 1999 10.2210/pdb1bzg/pdb pdb_00001bzg 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4027.636 PARATHYROID HORMONE-RELATED PROTEIN RESIDUES 1-34 1 man polymer no no AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1999-05-18 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1998-10-28 REL REL ENERGY, AGREEMENT WITH EXPERIMENTAL DATA 100 30 DQF-COSY CLEAN-TOCSY NOESY 550mM 5.1 10E+5PA atm 277 K STRATEGY USED FOR NMR STRUCTURE CALCULATION: EXPERIMENTAL RESTRAINTS FOR THE STRUCTURE CALCULATIONS INITIALLY, FREQUENCY DEGENERATED NOESY CROSS-PEAKS WERE INCORPORATED INTO THE STRUCTURE CALCULATION AS 'AMBIGUOUS'. SUBSEQUENTLY, THE PROTON- PROTON DISTANCES IN THE CALCULATED STRUCTURES WERE DETERMINED USING THE PROGRAM BACKCALC_DB 2.0 (SOFTWARE SYMBIOSE, INC., BAYREUTH, GERMANY) AND COMPARED WITH THE COMBINATIONS OF DISTANCES POSSIBLE FOR EACH FREQUENCY DEGENERATED NOESY CROSS-PEAK. IF ONLY ONE OF THE POSSIBLE DISTANCE COMBINATIONS WAS FULFILLED IN MORE THAN 50% OF THE CALCULATED STRUCTURES, THE DISTANCE INFORMATION WAS USED IN FURTHER STRUCTURE CALCULATIONS. THIS PROCEDURE WAS REPEATED SEVERAL TIMES, LEADING TO A TOTAL OF 424 INTRARESIDUAL AND 337 INTERRESIDUAL NOE CONNECTIVITIES. STRUCTURES CALCULATIONS WERE PERFORMED USING A MODIFIED AB INITIO SIMULATED ANNEALING PROTOCOL (NILGES, UNPUBLISHED) WITH X-PLOR V3.840. THE CALCULATION STRATEGY INCLUDES FLOATING ASSIGNMENT OF PROCHIRAL GROUPS AND A REDUCED PRESENTATION FOR NON-BONDED INTERACTIONS FOR PART OF THE CALCULATION TO INCREASE EFFICIENCY. A MORE DETAILED DESCRIPTION OF THE PROTOCOL IS GIVEN IN KHARRAT ET AL. (EMBO J. 14 (1995) 3572-84). STRUCTURE PARAMETERS WERE EXTRACTED FROM THE STANDARD FILES PARALLHDG.PRO AND TOPALLHDG.PRO OF X-PLOR V3.840. IN EACH ROUND OF THE STRUCTURE CALCULATION 100 STRUCTURES WERE CALCULATED. OF THE 100 STRUCTURES RESULTING FROM THE FINAL ROUND OF STRUCTURE CALCULATION, THOSE 30 STRUCTURES THAT SHOWED THE LOWEST TOTAL ENERGY VALUES WERE SELECTED FOR FURTHER CHARACTERIZATION. SIMULATED ANNEALING, RESTRAINED MOLECULAR DYNAMICS 1 H2O/D2O (9:1) BRUNGER refinement X-PLOR V3.840 V3.840 structure solution NDEE 2.0 structure solution X-PLOR 600 Bruker AMX600 ALA 1 n 1 ALA 1 A VAL 2 n 2 VAL 2 A SER 3 n 3 SER 3 A GLU 4 n 4 GLU 4 A HIS 5 n 5 HIS 5 A GLN 6 n 6 GLN 6 A LEU 7 n 7 LEU 7 A LEU 8 n 8 LEU 8 A HIS 9 n 9 HIS 9 A ASP 10 n 10 ASP 10 A LYS 11 n 11 LYS 11 A GLY 12 n 12 GLY 12 A LYS 13 n 13 LYS 13 A SER 14 n 14 SER 14 A ILE 15 n 15 ILE 15 A GLN 16 n 16 GLN 16 A ASP 17 n 17 ASP 17 A LEU 18 n 18 LEU 18 A ARG 19 n 19 ARG 19 A ARG 20 n 20 ARG 20 A ARG 21 n 21 ARG 21 A PHE 22 n 22 PHE 22 A PHE 23 n 23 PHE 23 A LEU 24 n 24 LEU 24 A HIS 25 n 25 HIS 25 A HIS 26 n 26 HIS 26 A LEU 27 n 27 LEU 27 A ILE 28 n 28 ILE 28 A ALA 29 n 29 ALA 29 A GLU 30 n 30 GLU 30 A ILE 31 n 31 ILE 31 A HIS 32 n 32 HIS 32 A THR 33 n 33 THR 33 A ALA 34 n 34 ALA 34 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A O H PHE HIS 22 26 1.47 1 A A O H LYS ILE 13 15 1.50 2 A A O H PHE HIS 22 26 1.50 2 A A O H ASP ARG 17 21 1.50 2 A A O H LYS ILE 13 15 1.57 2 A A O H HIS ALA 25 29 1.57 3 A A O H PHE HIS 22 26 1.46 4 A A O H PHE HIS 22 26 1.46 4 A A O H LYS ILE 13 15 1.52 5 A A O H SER ASP 14 17 1.32 5 A A O H PHE HIS 22 26 1.52 5 A A O H GLY SER 12 14 1.53 5 A A O H ILE ARG 15 19 1.57 6 A A O H HIS ALA 26 29 1.60 6 A A O H PHE HIS 22 26 1.60 7 A A O H SER ASP 14 17 1.33 7 A A O H PHE HIS 22 26 1.45 7 A A O H GLY SER 12 14 1.55 7 A A O H HIS ALA 26 29 1.55 7 A A O H ILE ARG 15 19 1.56 9 A A O H ASP ARG 17 21 1.38 9 A A O H PHE HIS 22 26 1.49 9 A A O H LYS ILE 13 15 1.53 9 A A O H ARG PHE 19 23 1.60 10 A A O H SER ASP 14 17 1.32 10 A A O H GLY SER 12 14 1.54 10 A A O H PHE HIS 22 26 1.60 11 A A O H SER ASP 14 17 1.29 11 A A O H ASP LYS 10 13 1.48 11 A A O H GLY SER 12 14 1.52 11 A A O H SER GLN 3 6 1.57 11 A A O H ILE ARG 15 19 1.58 12 A A O H PHE HIS 22 26 1.42 12 A A O H LYS ILE 13 15 1.50 13 A A O H SER ASP 14 17 1.30 13 A A O H LEU ALA 27 29 1.58 14 A A O H SER ASP 14 17 1.32 14 A A O H PHE HIS 22 26 1.38 14 A A O H ILE ARG 15 19 1.50 14 A A O H GLY SER 12 14 1.54 15 A A O H ASP ARG 17 21 1.42 15 A A O H PHE HIS 22 26 1.50 15 A A O H LEU ALA 27 29 1.56 16 A A O H HIS HIS 5 9 1.44 16 A A O H PHE HIS 22 26 1.51 16 A A O H SER LEU 14 18 1.54 17 A A O H ASP ARG 17 21 1.45 17 A A O H PHE HIS 22 26 1.51 18 A A O H ASP ARG 17 21 1.49 18 A A O H PHE HIS 22 26 1.50 18 A A O H SER GLN 3 6 1.58 19 A A O H ASP ARG 17 21 1.38 19 A A O H GLY SER 12 14 1.48 19 A A O H PHE HIS 22 26 1.58 20 A A O H SER ASP 14 17 1.27 20 A A O H ASP LYS 10 13 1.50 20 A A O H PHE HIS 22 26 1.51 20 A A O H ILE ARG 15 19 1.51 20 A A O H GLY SER 12 14 1.53 20 A A O H HIS ALA 26 29 1.56 20 A A O H HIS HIS 5 9 1.60 21 A A O H SER ASP 14 17 1.33 21 A A O H PHE HIS 22 26 1.54 21 A A O N GLN LEU 6 8 2.16 22 A A O H SER ASP 14 17 1.21 22 A A O H ASP ARG 17 21 1.39 22 A A O H PHE HIS 22 26 1.45 22 A A O H ARG PHE 19 23 1.59 23 A A O H PHE HIS 22 26 1.44 23 A A O H ASP ARG 17 21 1.48 24 A A O H SER ASP 14 17 1.30 24 A A O H GLY SER 12 14 1.54 24 A A O H HIS HIS 5 9 1.58 24 A A O H ILE ARG 15 19 1.58 25 A A O H ASP ARG 17 21 1.41 25 A A O H PHE HIS 22 26 1.44 25 A A O H LYS ILE 13 15 1.52 25 A A O H HIS HIS 5 9 1.54 26 A A O H PHE HIS 22 26 1.40 26 A A O H HIS HIS 5 9 1.52 26 A A O H ASP ARG 17 21 1.55 27 A A O H PHE HIS 22 26 1.47 27 A A O H LYS ILE 13 15 1.51 27 A A O H HIS HIS 5 9 1.56 27 A A O H SER GLN 3 6 1.60 28 A A O H PHE HIS 22 26 1.42 28 A A O H GLN ARG 16 20 1.46 28 A A O H LYS ILE 13 15 1.53 28 A A O H ASP ARG 17 21 1.55 29 A A O H PHE HIS 22 26 1.45 29 A A O H HIS HIS 5 9 1.57 29 A A O H GLN LEU 6 8 1.59 29 A A O H LYS ILE 13 15 1.59 1 A ARG 19 0.169 SIDE CHAIN 1 A ARG 20 0.316 SIDE CHAIN 1 A ARG 21 0.165 SIDE CHAIN 2 A ARG 19 0.237 SIDE CHAIN 2 A ARG 21 0.313 SIDE CHAIN 3 A ARG 19 0.240 SIDE CHAIN 3 A ARG 20 0.283 SIDE CHAIN 3 A ARG 21 0.304 SIDE CHAIN 4 A ARG 19 0.244 SIDE CHAIN 4 A ARG 20 0.315 SIDE CHAIN 4 A ARG 21 0.314 SIDE CHAIN 5 A ARG 19 0.192 SIDE CHAIN 5 A ARG 20 0.180 SIDE CHAIN 5 A ARG 21 0.232 SIDE CHAIN 6 A ARG 19 0.234 SIDE CHAIN 6 A ARG 20 0.121 SIDE CHAIN 6 A ARG 21 0.306 SIDE CHAIN 7 A ARG 19 0.210 SIDE CHAIN 7 A ARG 20 0.271 SIDE CHAIN 7 A ARG 21 0.318 SIDE CHAIN 8 A ARG 19 0.269 SIDE CHAIN 8 A ARG 20 0.158 SIDE CHAIN 8 A ARG 21 0.249 SIDE CHAIN 9 A ARG 19 0.231 SIDE CHAIN 9 A ARG 20 0.208 SIDE CHAIN 9 A ARG 21 0.318 SIDE CHAIN 10 A ARG 19 0.113 SIDE CHAIN 10 A ARG 20 0.123 SIDE CHAIN 10 A ARG 21 0.308 SIDE CHAIN 11 A ARG 19 0.241 SIDE CHAIN 11 A ARG 21 0.253 SIDE CHAIN 12 A ARG 19 0.137 SIDE CHAIN 12 A ARG 20 0.271 SIDE CHAIN 12 A ARG 21 0.283 SIDE CHAIN 13 A ARG 19 0.201 SIDE CHAIN 13 A ARG 20 0.317 SIDE CHAIN 13 A ARG 21 0.161 SIDE CHAIN 14 A ARG 19 0.242 SIDE CHAIN 14 A ARG 20 0.133 SIDE CHAIN 14 A ARG 21 0.283 SIDE CHAIN 15 A ARG 19 0.256 SIDE CHAIN 15 A ARG 20 0.251 SIDE CHAIN 15 A ARG 21 0.209 SIDE CHAIN 16 A ARG 19 0.152 SIDE CHAIN 16 A ARG 20 0.259 SIDE CHAIN 16 A ARG 21 0.273 SIDE CHAIN 17 A ARG 19 0.269 SIDE CHAIN 17 A ARG 20 0.270 SIDE CHAIN 17 A ARG 21 0.314 SIDE CHAIN 18 A ARG 19 0.287 SIDE CHAIN 18 A ARG 20 0.288 SIDE CHAIN 18 A ARG 21 0.317 SIDE CHAIN 19 A ARG 19 0.268 SIDE CHAIN 19 A ARG 20 0.293 SIDE CHAIN 19 A ARG 21 0.312 SIDE CHAIN 20 A ARG 19 0.315 SIDE CHAIN 20 A ARG 20 0.183 SIDE CHAIN 20 A ARG 21 0.218 SIDE CHAIN 21 A ARG 19 0.138 SIDE CHAIN 21 A ARG 20 0.205 SIDE CHAIN 21 A ARG 21 0.091 SIDE CHAIN 22 A ARG 19 0.223 SIDE CHAIN 22 A ARG 20 0.306 SIDE CHAIN 22 A ARG 21 0.315 SIDE CHAIN 23 A ARG 19 0.179 SIDE CHAIN 23 A ARG 21 0.202 SIDE CHAIN 24 A ARG 19 0.156 SIDE CHAIN 24 A ARG 20 0.204 SIDE CHAIN 24 A ARG 21 0.295 SIDE CHAIN 25 A ARG 19 0.260 SIDE CHAIN 25 A ARG 20 0.318 SIDE CHAIN 25 A ARG 21 0.081 SIDE CHAIN 26 A ARG 19 0.243 SIDE CHAIN 26 A ARG 21 0.300 SIDE CHAIN 27 A ARG 19 0.273 SIDE CHAIN 27 A ARG 20 0.303 SIDE CHAIN 27 A ARG 21 0.314 SIDE CHAIN 28 A ARG 19 0.315 SIDE CHAIN 28 A ARG 20 0.296 SIDE CHAIN 28 A ARG 21 0.260 SIDE CHAIN 29 A ARG 19 0.241 SIDE CHAIN 29 A ARG 20 0.173 SIDE CHAIN 29 A ARG 21 0.309 SIDE CHAIN 30 A ARG 19 0.296 SIDE CHAIN 30 A ARG 20 0.210 SIDE CHAIN 30 A ARG 21 0.281 SIDE CHAIN 1 A VAL 2 -43.58 157.05 1 A GLN 6 -48.90 172.52 1 A LEU 7 69.16 -69.88 1 A HIS 9 -98.69 45.21 1 A ASP 10 -25.77 -47.11 1 A LYS 11 -43.92 93.41 1 A LYS 13 -57.09 -161.87 1 A SER 14 -69.37 58.62 1 A PHE 23 -18.67 -75.94 1 A ILE 28 -147.94 57.18 1 A ALA 29 162.35 93.75 1 A GLU 30 172.61 106.24 1 A HIS 32 -59.55 89.19 2 A VAL 2 -42.15 150.96 2 A GLN 6 -45.43 159.45 2 A LEU 7 75.30 -50.02 2 A ASP 10 -37.25 93.17 2 A LYS 13 -55.21 -166.50 2 A ILE 15 -147.44 -51.05 2 A PHE 23 -22.62 -73.97 2 A ALA 29 175.08 150.84 2 A HIS 32 -38.49 107.17 3 A GLN 6 -45.32 162.37 3 A LEU 7 76.83 -49.39 3 A LYS 13 -77.14 -156.81 3 A PHE 23 -21.76 -66.43 3 A ALA 29 162.60 145.36 4 A VAL 2 -42.36 154.28 4 A GLN 6 -86.20 32.87 4 A HIS 9 -44.05 -74.41 4 A LYS 11 38.35 28.54 4 A LYS 13 -101.61 -152.94 4 A PHE 23 -21.45 -79.59 4 A ALA 29 -151.54 41.20 4 A GLU 30 159.94 82.76 5 A GLN 6 -48.66 172.10 5 A LEU 7 70.95 -66.96 5 A ASP 10 21.50 -94.53 5 A LYS 11 22.90 87.55 5 A LYS 13 -66.44 62.46 5 A SER 14 44.28 96.20 5 A ILE 15 -25.36 -39.41 5 A PHE 23 -23.47 -77.32 5 A ILE 28 -100.73 50.76 5 A ALA 29 165.48 86.92 5 A GLU 30 -164.66 50.86 5 A HIS 32 161.98 62.90 6 A VAL 2 49.60 19.44 6 A LEU 7 -94.21 -66.73 6 A HIS 9 -88.20 38.42 6 A ASP 10 -40.06 88.98 6 A LYS 11 -53.70 100.46 6 A LYS 13 -67.88 -155.20 6 A PHE 23 -20.95 -60.04 6 A ALA 29 179.58 149.47 7 A GLU 4 -54.14 -97.28 7 A GLN 6 -43.62 163.46 7 A LEU 7 73.11 -52.05 7 A ASP 10 -33.26 104.20 7 A LYS 13 -68.18 62.01 7 A SER 14 45.22 99.01 7 A ILE 15 -37.37 -29.62 7 A PHE 23 -22.71 -78.74 7 A ALA 29 164.65 133.49 7 A GLU 30 -69.93 56.48 7 A HIS 32 -53.46 87.04 7 A THR 33 43.60 74.76 8 A VAL 2 -42.42 162.05 8 A GLN 6 -47.67 171.80 8 A LEU 7 69.48 -70.22 8 A HIS 9 -98.22 41.37 8 A ASP 10 -30.02 147.61 8 A LYS 11 -86.05 30.93 8 A SER 14 31.40 40.27 8 A PHE 23 -24.11 -69.05 8 A ALA 29 165.42 120.57 8 A HIS 32 45.99 84.16 8 A THR 33 53.65 101.36 9 A GLU 4 -71.24 -71.06 9 A GLN 6 -44.92 160.53 9 A LEU 7 74.47 -51.66 9 A ASP 10 -39.62 -28.98 9 A LYS 11 -42.69 91.37 9 A LYS 13 -56.35 -164.38 9 A SER 14 -69.80 62.42 9 A PHE 23 -11.27 -75.90 9 A HIS 26 -86.37 -73.78 9 A ILE 28 -97.60 46.10 9 A ALA 29 162.35 117.41 9 A ILE 31 31.40 84.94 9 A THR 33 44.68 96.03 10 A VAL 2 -42.18 152.53 10 A GLN 6 -45.51 159.09 10 A LEU 7 75.35 -51.84 10 A ASP 10 28.02 -88.27 10 A LYS 11 1.37 83.95 10 A LYS 13 -68.41 62.04 10 A SER 14 46.05 98.28 10 A ILE 15 -36.56 -30.20 10 A PHE 23 -24.98 -75.81 10 A ILE 28 -155.36 -37.25 10 A ALA 29 170.90 138.70 10 A THR 33 60.37 164.66 11 A SER 3 39.50 98.82 11 A GLN 6 -44.94 161.14 11 A LEU 7 74.16 -52.35 11 A ASP 10 28.67 -87.40 11 A LYS 11 -40.96 95.58 11 A LYS 13 -67.57 63.04 11 A SER 14 38.46 97.45 11 A ILE 15 -29.96 -37.32 11 A PHE 23 -24.45 -82.37 11 A HIS 26 -74.95 -74.51 11 A ILE 28 -76.43 -93.61 11 A ALA 29 -45.66 164.22 11 A GLU 30 44.01 -173.54 11 A HIS 32 50.76 83.88 11 A THR 33 71.72 151.47 12 A GLN 6 -47.19 160.64 12 A LEU 7 75.64 -50.97 12 A ASP 10 25.55 89.61 12 A LYS 11 -43.61 99.89 12 A LYS 13 -56.62 -162.08 12 A SER 14 -68.10 58.86 12 A PHE 23 -20.91 -73.88 12 A ALA 29 165.76 124.83 12 A HIS 32 -43.67 150.90 13 A VAL 2 42.08 -168.05 13 A GLN 6 -50.07 174.86 13 A LEU 7 68.55 -67.01 13 A HIS 9 -93.76 38.07 13 A ASP 10 -33.33 92.37 13 A LYS 13 -65.71 70.59 13 A SER 14 28.23 99.73 13 A ILE 15 -35.27 -33.46 13 A PHE 23 -23.11 -78.61 13 A LEU 27 -51.00 -178.92 13 A ILE 28 66.80 -59.85 13 A ALA 29 -163.52 90.83 14 A LEU 7 -102.00 -66.70 14 A HIS 9 -93.96 44.21 14 A ASP 10 -39.07 92.34 14 A LYS 13 -68.43 62.05 14 A SER 14 42.46 95.09 14 A ILE 15 -36.07 -31.74 14 A PHE 23 -23.88 -54.61 14 A ALA 29 170.58 159.54 14 A GLU 30 -171.84 136.52 14 A HIS 32 -107.58 51.17 15 A SER 3 38.53 97.04 15 A GLN 6 -49.07 172.85 15 A LEU 7 71.93 -66.71 15 A ASP 10 28.07 79.85 15 A LYS 13 52.14 133.93 15 A SER 14 39.08 35.86 15 A PHE 23 -22.16 -76.12 15 A LEU 27 -63.38 -166.92 15 A ILE 28 66.04 -57.64 15 A GLU 30 59.19 114.16 15 A HIS 32 165.40 71.85 15 A THR 33 -150.97 54.78 16 A SER 3 -56.57 177.66 16 A GLN 6 -46.94 168.50 16 A LEU 7 68.01 -69.16 16 A LYS 13 -23.56 151.90 16 A PHE 23 -17.48 -76.25 16 A HIS 26 -85.35 -74.03 16 A ILE 28 -68.03 -90.68 16 A ALA 29 -54.87 170.16 16 A ILE 31 -107.48 43.54 16 A HIS 32 -55.38 82.06 17 A VAL 2 -43.97 161.77 17 A GLN 6 -42.62 158.41 17 A LEU 7 76.01 -49.58 17 A ASP 10 -39.33 92.53 17 A LYS 13 52.41 131.80 17 A PHE 23 -27.27 -82.23 17 A LEU 27 -36.36 -30.75 17 A ILE 28 -107.37 -88.39 17 A GLU 30 -173.76 140.37 17 A ILE 31 56.12 111.01 18 A SER 3 40.51 101.50 18 A GLN 6 -47.25 170.24 18 A LEU 7 69.81 -67.47 18 A HIS 9 -48.58 -76.03 18 A LYS 11 44.08 23.08 18 A LYS 13 53.28 133.38 18 A PHE 23 -13.58 -78.34 18 A ALA 29 162.36 114.38 18 A HIS 32 -44.93 95.70 18 A THR 33 -69.00 87.69 19 A VAL 2 -49.79 152.57 19 A GLN 6 -46.30 163.12 19 A LEU 7 73.08 -52.56 19 A LYS 11 -73.73 42.62 19 A LYS 13 -60.62 48.27 19 A ILE 15 164.77 -64.89 19 A PHE 23 -18.55 -77.33 19 A ALA 29 162.54 -178.48 19 A GLU 30 178.75 143.56 19 A THR 33 53.97 102.57 20 A GLN 6 -45.65 167.54 20 A LEU 7 70.81 -63.32 20 A ASP 10 26.87 -89.04 20 A LYS 11 -40.69 89.83 20 A SER 14 53.26 92.64 20 A ILE 15 -34.29 -32.16 20 A GLN 16 -31.06 -38.44 20 A PHE 23 -22.35 -78.21 20 A ALA 29 49.71 95.71 21 A GLU 4 -57.61 -71.47 21 A HIS 5 -42.24 -95.61 21 A GLN 6 42.22 -160.08 21 A LEU 7 39.49 -79.50 21 A ASP 10 20.48 55.14 21 A LYS 13 37.18 69.72 21 A SER 14 57.36 97.89 21 A ILE 15 -37.37 -28.82 21 A GLN 16 -32.55 -39.24 21 A PHE 23 -22.65 -75.74 21 A ALA 29 159.69 84.55 22 A GLN 6 -49.56 175.21 22 A LEU 7 68.48 -68.71 22 A HIS 9 -97.13 39.30 22 A ASP 10 -28.69 93.06 22 A LYS 11 -50.07 88.86 22 A LYS 13 32.37 38.67 22 A SER 14 49.57 90.89 22 A ILE 15 -34.47 -27.92 22 A GLN 16 -37.79 -31.58 22 A PHE 23 -11.19 -74.85 22 A ALA 29 175.37 159.54 22 A GLU 30 54.89 101.34 22 A HIS 32 38.60 50.99 23 A GLN 6 -45.72 161.09 23 A LEU 7 75.88 -50.80 23 A ASP 10 29.18 87.33 23 A LYS 11 -43.53 102.70 23 A LYS 13 -67.99 -159.77 23 A PHE 23 -21.55 -70.56 23 A ALA 29 172.41 116.68 23 A GLU 30 -167.95 78.05 24 A GLU 4 -83.98 -71.01 24 A GLN 6 -46.82 167.35 24 A LEU 7 67.87 -69.52 24 A HIS 9 -45.11 -78.59 24 A LYS 11 -47.63 88.42 24 A LYS 13 -69.16 64.46 24 A SER 14 41.16 100.26 24 A ILE 15 -33.95 -34.88 24 A PHE 23 -24.90 -82.62 24 A LEU 27 -24.53 -88.57 24 A ILE 28 -53.90 -84.21 24 A ALA 29 -63.82 91.14 24 A HIS 32 168.34 57.02 25 A VAL 2 -42.88 156.42 25 A GLN 6 -45.65 164.79 25 A LEU 7 67.71 -68.18 25 A HIS 9 -41.45 -82.64 25 A ASP 10 -81.09 -110.98 25 A LYS 11 35.52 31.28 25 A LYS 13 -57.48 -157.19 25 A SER 14 -67.87 62.68 25 A PHE 23 -23.54 -83.55 25 A ILE 28 40.55 23.36 25 A ALA 29 62.80 160.23 25 A HIS 32 -46.18 109.63 25 A THR 33 76.16 124.74 26 A VAL 2 -43.77 157.88 26 A GLU 4 -86.44 -74.00 26 A GLN 6 -47.23 169.78 26 A LEU 7 72.95 -63.84 26 A ASP 10 15.81 108.28 26 A LYS 13 -55.21 -164.38 26 A PHE 23 -15.09 -74.14 26 A ILE 28 -72.34 -87.64 26 A GLU 30 40.16 75.27 26 A HIS 32 174.87 144.05 27 A VAL 2 -43.17 159.76 27 A SER 3 37.88 93.88 27 A GLN 6 -49.77 175.38 27 A LEU 7 70.19 -70.05 27 A HIS 9 -91.03 37.37 27 A ASP 10 -34.43 94.05 27 A LYS 11 -66.70 99.97 27 A LYS 13 -58.23 -155.41 27 A SER 14 -68.93 61.87 27 A PHE 23 -20.10 -71.13 27 A ILE 28 -85.41 -74.58 27 A GLU 30 -177.99 70.59 27 A HIS 32 -53.22 87.05 27 A THR 33 -101.62 51.43 28 A GLN 6 -47.32 170.40 28 A LEU 7 69.32 -68.62 28 A HIS 9 -90.61 35.49 28 A ASP 10 -25.81 124.46 28 A LYS 13 -55.40 -164.09 28 A SER 14 -69.34 60.95 28 A ARG 19 -90.94 -63.01 28 A PHE 23 -27.07 -70.53 28 A HIS 26 -54.47 -72.78 28 A ALA 29 77.91 71.22 28 A HIS 32 -56.10 105.66 28 A THR 33 46.75 -171.66 29 A VAL 2 52.03 18.70 29 A GLN 6 -47.56 172.65 29 A LEU 7 69.33 -62.84 29 A ASP 10 24.12 -88.77 29 A LYS 11 36.22 30.35 29 A LYS 13 -59.52 -165.45 29 A PHE 23 -19.43 -75.72 29 A ALA 29 162.08 -179.10 29 A GLU 30 50.11 73.00 29 A ILE 31 -144.57 44.19 29 A HIS 32 -38.17 105.37 29 A THR 33 -108.01 67.23 30 A VAL 2 -43.26 158.51 30 A GLU 4 -100.15 -62.50 30 A LEU 7 -98.50 -68.46 30 A ASP 10 28.79 -99.94 30 A LYS 11 33.54 32.26 30 A LYS 13 -55.11 -163.42 30 A PHE 23 -20.61 -69.97 30 A ALA 29 172.08 82.55 model building X-PLOR 3.0 refinement X-PLOR 3.0 phasing X-PLOR 3.0 THE SOLUTION STRUCTURE OF HUMAN PARATHYROID HORMONE-RELATED PROTEIN (1-34) IN NEAR-PHYSIOLOGICAL SOLUTION, NMR, 30 STRUCTURES 1 Y N A HIS 5 A HIS 5 HELX_P A LEU 8 A LEU 8 1 1 4 A GLN 16 A GLN 16 HELX_P A LEU 27 A LEU 27 1 2 12 HORMONE HUMAN PEPTIDE HORMONE, STIMULATING INTRACELLULAR CAMP FORMATION, SERUM CALCIUM LEVEL, HUMORAL HYPERCALCEMIA OF MALIGNANCY, SOLUTION STRUCTURE, PTHRP, PTH, HORMONE PTHR_HUMAN UNP 1 1 P12272 MQRRLVQQWSVAVFLLSYAVPSCGRSVEGLSRRLKRAVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIRATSEVSP NSKPSPNTKNHPVRFGSDDEGRYLTQETNKVETYKEQPLKTPGKKKKGKPGKRKEQEKKKRRTRSAWLDSGVTGSGLEGD HLSDTSTTSLELDSRRH 37 70 1BZG 1 34 P12272 A 1 1 34 1 P 1